Exploring treatment options in cancer: tumor treatment strategies
Traditional therapeutic approaches such as chemotherapy and radiation therapy have
burdened cancer patients with onerous physical and psychological challenges …
burdened cancer patients with onerous physical and psychological challenges …
Immunosurveillance in clinical cancer management
The progression of cancer involves a critical step in which malignant cells escape from
control by the immune system. Antineoplastic agents are particularly efficient when they …
control by the immune system. Antineoplastic agents are particularly efficient when they …
Peptide-based agents for cancer treatment: current applications and future directions
Peptide-based strategies have received an enormous amount of attention because of their
specificity and applicability. Their specificity and tumor-targeting ability are applied to …
specificity and applicability. Their specificity and tumor-targeting ability are applied to …
Cranioencephalic functional lymphoid units in glioblastoma
C Dobersalske, L Rauschenbach, Y Hua, C Berliner… - Nature medicine, 2024 - nature.com
The ecosystem of brain tumors is considered immunosuppressed, but our current
knowledge may be incomplete. Here we analyzed clinical cell and tissue specimens derived …
knowledge may be incomplete. Here we analyzed clinical cell and tissue specimens derived …
Potential targeting of the tumor microenvironment to improve cancer virotherapy
In 2015, oncolytic virotherapy was approved for clinical use, and in 2017, recombinant
adeno-associated virus (AAV) delivery was also approved. However, systemic …
adeno-associated virus (AAV) delivery was also approved. However, systemic …
Oncolytic virotherapy in cancer treatment: challenges and optimization prospects
L Chen, M Zuo, Q Zhou, Y Wang - Frontiers in Immunology, 2023 - frontiersin.org
Oncolytic viruses (OVs) are emerging cancer therapeutics that offer a multifaceted
therapeutic platform for the benefits of replicating and lysing tumor cells, being engineered …
therapeutic platform for the benefits of replicating and lysing tumor cells, being engineered …
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Glioblastoma (GBM) is an aggressive and lethal type of brain tumor in human adults. The
standard of care offers minimal clinical benefit, and most GBM patients experience tumor …
standard of care offers minimal clinical benefit, and most GBM patients experience tumor …
Glioblastoma therapy: past, present and future
E Obrador, P Moreno-Murciano… - International journal of …, 2024 - mdpi.com
Glioblastoma (GB) stands out as the most prevalent and lethal form of brain cancer.
Although great efforts have been made by clinicians and researchers, no significant …
Although great efforts have been made by clinicians and researchers, no significant …
Glioblastoma vaccines: past, present, and opportunities
Glioblastoma (GBM) is one of the most lethal central nervous systems (CNS) tumours in
adults. As supplements to standard of care (SOC), various immunotherapies improve the …
adults. As supplements to standard of care (SOC), various immunotherapies improve the …
'Slicing'glioblastoma drivers with the Swiss cheese model
The Swiss cheese model is used to assess risks and explain accidents in a variety of
industries. This model can be applied to dissect the homeostatic mechanisms whose …
industries. This model can be applied to dissect the homeostatic mechanisms whose …